Vanda Pharmaceuticals Inc. News Headlines

Get VNDA Alerts
*Delayed - data as of Jan. 30, 2015  -  Find a broker to begin trading VNDA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Filtered By
Ordered By
Use Options For a Chance To Buy VNDA at a 44% Discount
1/9/2015 12:12:12 PM - BNK Invest

Cellceutix Overvalued By 90-99%
1/2/2015 5:21:00 PM - Seeking Alpha

Vanda Pharmaceuticals shares bought
12/26/2014 11:31:00 AM - InvestorsObserver

Vanda Gains Fanapt Rights from Novartis for the U.S. Region - Analyst Blog
12/24/2014 4:30:00 PM -

Why the bulls are chasing Vanda
12/24/2014 6:16:24 AM - optionMONSTER

Vanda Gains Fanapt Rights from Novartis for the U.S. Region - Analyst Blog
12/24/2014 4:30:00 AM - Investopedia

Health Care Sector Update for 12/23/2014: VNDA,NVS,CRMD,ACHN
12/23/2014 1:06:56 PM - MT Newswires

European Extend Rally On Robust U.S. GDP -- Canadian Commentary
12/23/2014 12:14:00 PM - RTT News

Mid-Morning Market Update: Markets Mostly Higher; Walgreen Profit Beats Expectations
12/23/2014 10:40:17 AM - Benzinga

Vanda Pharmaceuticals Inc. (VNDA) Is Up Sharply After Novartis Settlement
12/23/2014 9:35:00 AM - RTT News

U.S. Hot Stocks: Hot Stocks to Watch
12/23/2014 9:04:00 AM - Dow Jones Business News

US Stocks Poised For Flat Open Ahead Of Data Deluge
12/23/2014 6:30:00 AM - RTT News

Vanda Settle Fanapt Arbitration With Novartis
12/22/2014 7:14:00 PM - RTT News

Vanda, Novartis Settle Drug Licensing Dispute
12/22/2014 5:55:00 PM - Dow Jones Business News

Vanda, Novartis Settle Licensing Dispute Over Schizophrenia Drug
12/22/2014 5:29:00 PM - Dow Jones Business News

Use Options For a Chance To Buy VNDA at a 30% Discount
12/11/2014 11:55:46 AM - BNK Invest

Vanda Pharma To Present At Piper Jaffray Conference; Webcast At 2:30 PM ET
12/3/2014 1:30:00 PM - RTT News

Idera Pharma Appoints Vincent Milano As CEO
12/2/2014 12:04:00 AM - RTT News

Vanda Pharma Present At Stifel Nicolaus Conference; Webcast At 11:30 AM ET
11/19/2014 10:31:00 AM - RTT News

Commit To Buy Vanda Pharmaceuticals At $7, Earn 15% Using Options
11/6/2014 11:54:16 AM - BNK Invest

Sector Update: Health-Care Shares Flat Before Opening Bell
10/27/2014 7:49:25 AM - MT Newswires

Sector Update: Health Care
10/27/2014 7:45:32 AM - MT Newswires

Vanda Up on EU News - Analyst Blog
6/5/2014 6:01:00 PM -

Wednesday's ETF Movers: XBI, GXC
6/4/2014 2:23:26 PM - BNK Invest

Healthcare Stocks Mixed; Vanda Pharmaceutical Adds More Than 25% After 'Non-24' Medication Wins Orphan Drug Status in Europe
6/4/2014 12:43:29 PM - MT Newswires